How the immune system positions its gatekeepers

March 19, 2013
How the immune system positions its gatekeepers
Dendritic cells (red), B cells (green) and marginal zone bridging channels (blue) in the spleen.

(Medical Xpress)—For an immune response to get underway, an invading microbe must first be halted in the spleen, and then digested by immune cells known as 'dendritic cells', which guard specific portals. Australian scientists have now shown how these gatekeepers position themselves to undertake their task.

An immune response involves different interacting with one another to dispose of an invading organism or 'antigen'. capture viruses or bacteria, process them, then deliver information to other immune cells known as T , which in turn deliver information to , the makers of antibodies.

Dr Dominique Gatto and Associate Professor Robert Brink from Sydney's Garvan Institute of Medical Research have shown that the dendritic cells express a particular known as EBI2. They demonstrated that without EBI2, not only do these cells fail to marshall where they should, they fail to develop at all, effectively disabling the adaptive immune response. The findings are published online today in the journal Nature Immunology.

"It so happens that the parts of the spleen where these dendritic cells cluster, known as 'marginal zone bridging channels', are very important filtering points or portals, for capturing blood borne infections," said Associate Professor Brink.

"Blood seeps around the outside of the spleen, carrying antigens, and they tend to get trapped at these points, like particles in a sieve, allowing the exquisitely well-placed dendritic cells to capture them."

"When you see images of the way cells cluster in the spleen, the whole system looks remarkably like a well-organised transport hub, with a T cell area in the middle, B cell zones around that, and clear entry points, guarded by dendritic cells."

"Remove EBI2 and you don't have dendritic cells sitting where they have to be in order to capture antigens and activate other cells."

Movement of immune cells is always guided by 'ligands', or substances that attract cell surface receptors. The ligand for EBI2 is made in the spleen, and also attracts B cells that express EBI2.

Brink observed that the attraction of a receptor to a ligand is very similar to that of a moth to a flame. "It's how the body can organise these cells so exquisitely in three dimensions – can put them in exactly the right places for them to carry out their functions."

"While this is a basic science finding, it's a very important one that advances our understanding of how the works."

Explore further: Skin sentry cells promote distinct immune responses

More information: www.nature.com/ni/journal/vaop/ncurrent/full/ni.2555.html

Related Stories

Skin sentry cells promote distinct immune responses

July 21, 2011

A new study reveals that just as different soldiers in the field have different jobs, subsets of a type of immune cell that polices the barriers of the body can promote unique and opposite immune responses against the same ...

How excess alcohol depresses immune function

August 16, 2011

Alcoholism suppresses the immune system, resulting in a high risk of serious, and even life-threatening infections. A new study shows that this effect stems largely from alcohol’s toxicity to immune system cells called ...

Recommended for you

Epigenomic changes are key to innate immunological memory

August 31, 2015

A research team led by Keisuke Yoshida and Shunsuke Ishii of the RIKEN Molecular Genetics Laboratory has revealed that epigenomic changes induced by pathogen infections, mediated by a transcription factor called ATF7, are ...

Team finds early inflammatory response paralyzes T cells

August 18, 2015

In a discovery that is likely to rewrite immunology text books, researchers at UC Davis have found that early exposure to inflammatory cytokines, such as interleukin 2, can "paralyze" CD4 T cells, immune components that help ...

SIV shrugs off antibodies in vaccinated monkeys

August 11, 2015

New research on monkeys vaccinated against HIV's relative SIV calls into question an idea that has driven AIDS vaccine work for years. The assumption: a protective vaccine only needs to stimulate moderate levels of antibodies ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.